EUVIMEDEUVIMED entdecken
Crossref

HPV Genotype as a Predictor of Bevacizumab Treatment Response in Recurrent Respiratory Papillomatosis Patients

ENT Discovery · 2025

DOI: 10.15302/entd.2025.090004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ENT Discovery, 2025.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2025). HPV Genotype as a Predictor of Bevacizumab Treatment Response in Recurrent Respiratory Papillomatosis Patients. ENT Discovery. https://doi.org/10.15302/entd.2025.090004

Vancouver

HPV Genotype as a Predictor of Bevacizumab Treatment Response in Recurrent Respiratory Papillomatosis Patients. ENT Discovery. 2025. doi:10.15302/entd.2025.090004

BibTeX
@article{euvimed2025,
  title = {HPV Genotype as a Predictor of Bevacizumab Treatment Response in Recurrent Respiratory Papillomatosis Patients},
  journal = {ENT Discovery},
  year = {2025},
  doi = {10.15302/entd.2025.090004}
}
Kostenlos starten →